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http://dx.doi.org/10.1016/j.ccell.2014.09.010SUMMARYWe isolated and analyzed, at single-nucleotide resolution, cancer-associated neochromosomes from well-
and/or dedifferentiated liposarcomas. Neochromosomes, which can exceed 600 Mb in size, initially arise
as circular structures following chromothripsis involving chromosome 12. The core of the neochromosome
is amplified, rearranged, and corroded through hundreds of breakage-fusion-bridge cycles. Under selective
pressure, amplified oncogenes are overexpressed, while coamplified passenger genes may be silenced
epigenetically. New material may be captured during punctuated chromothriptic events. Centromeric corro-
sion leads to crisis, which is resolved through neocentromere formation or native centromere capture. Finally,
amplification terminates, and the neochromosome core is stabilized in linear form by telomere capture. This
study investigates the dynamic mutational processes underlying the life history of a special form of cancer
mutation.INTRODUCTION
Chromosomes are a fundamental organizational unit of genetic
information relevant to biology and disease. Contiguous se-Significance
Different cancers reveal distinctmutation patterns, frommisma
generate fusion genes in subtypes of leukemia. Neochromoso
tion of massive, episomal, self-replicating structures within ca
sarcomas. We describe, at single-nucleotide level, the structu
neochromosomes, and we used mathematical modeling to un
Canquences of circular or linear DNA and associated proteins from
0.1 Mb to 1 Gb in length (Paux et al., 2008), all nuclear chromo-
somes require centromeres and, when in linear form, telomeres
(Baird and Farr, 2006). In humans, in addition to 46 normaltch repair defects in colorectal cancers to translocations that
mes are a form of mutation comprising the somatic acquisi-
ncer cells, specific to certain cancer types, including several
re and content of well- and/or dedifferentiated liposarcoma
derstand their origins and oncogenic properties.
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Figure 1. Characterization and Analysis of WD/DDLPS Cell Lines
(A) Hierarchical clustering of bacterial artificial chromosome array-based comparative genomic hybridization of 21 primary WD/DDLPSs, 5 pleomorphic
liposarcomas (LPS), 4 undifferentiated pleomorphic sarcomas (MFH), and 5 leiomyosarcomas (LMS), as well as the 778 and 449 (indicated by stars)
and SW872 cell lines (LCL). In the heatmap, rows represent samples, and columns represent probes. Beneath the dendrogram is the corresponding
copy number heatmap (in landscape orientation). Heatmap color indicates the log2 copy number ratio (normal, log2 = 0); amplifications are red, and
deletions are green. Blue bars demarcate WD/DDLPS samples and cell lines. The arrowhead marks the defining amplification of regions from chromo-
some 12q.
(B) G-banded marker neochromosomes from the 778, 449, GOT3, and T1000 cell lines, compared to chromosome 1 (Chr1).
(C) Representative flow dot plot of chromosomes from the 778 cell lines, showing the position of normal chromosomes as well as two marker neochromosome
populations (circled). Chromosomes were stained for flow sorting with the fluorescent DNA-intercalating dyes as shown.
(legend continued on next page)
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The Life Cycle of Cancer Neochromosomeschromosomes, constitutive small marker supernumerary
chromosome-like structures have been observed, often with
developmental phenotypes (Liehr et al., 2006). Chromosomal
abnormalities are also common in cancer. Double minutes,
small, self-replicating extrachromosomal structures in a ring
form, were originally observed in sarcomas (Buoen and Brand,
1968). Supernumerary accessory chromosomes (hereinafter
referred to as neochromosomes) occur in 3% of all cancers,
including 14%ofmesenchymal tumors and 21%of glioblastoma
(Dahlback et al., 2009; Sanborn et al., 2013). Neochromosomes
are characteristic of several cancers, including well- and dedif-
ferentiated liposarcoma (WD/DDLPS), parosteal osteosarcoma,
and dermatofibrosarcoma protuberans (Garsed et al., 2009).
Pathogenetically, the concomitant amplification of oncogenes
such as MDM2 and CDK4 appears to drive carcinogenesis
(Barretina et al., 2010; Italiano et al., 2008; Pedeutour et al.,
1994; Pilotti et al., 1998).
Recently, new large-scale mutation patterns have been iden-
tified in cancer, including chromothripsis, kataegis, double
minutes, and recurrent amplification of megabase regions of
chromosome 21 (Li et al., 2014; Nik-Zainal et al., 2012; Sanborn
et al., 2013; Stephens et al., 2011). Here, we anatomize cancer-
associated neochromosomes, occurring in both circular form
(ring) and linear form (giant markers) and possessing key func-
tional structures in chromosomes, including centromere and
telomeric domains (Lo et al., 2002a, 2002b; Marshall et al.,
2008a). These features distinguish neochromosomes from dou-
ble minutes, which are episomally replicating circular structures
typically a few megabases in size and lacking recognizable
centromeres and telomeres (Sanborn et al., 2013). Integrating
structural mapping with mathematical simulations, we describe
the evolution of these neochromosomes under oncogenic selec-
tion and, using transcriptional and copy number data from cell
lines and primary tumors combined with functional studies,
investigate a potential oncogene, NUP107.
RESULTS
Cytogenetic and Array-Based Mapping of WD/DDLPS
Genomes
Wefirst profiled isolated neochromosomes from fiveWD/DDLPS
cell lines (449, 778, GOT3, T1000, and LPS141) (Pedeutour et al.,
2012; Persson et al., 2008; Sirvent et al., 2000; Stratford et al.,
2012). It is important to note that the 449 and 778 cell lines
were independently derived from the same tumor (449 was es-
tablished in 1993, and 778 was established from a recurrence
in 1994; Sirvent et al., 2000), a feature enabling insights into
conserved and divergent aspects of neochromosome evolution.
The copy number profiles of the 449 and 778 cell lines recapitu-
late primary WD/DDLPS tumors, characterized by high-level
chromosome 12 copy number gains (Figure 1A). Initial karyotyp-
ing (Figure 1B) and multicolor fluorescence in situ hybridization(D) SNP array copy number analysis of the total DNA from the 778 cell line (778),
778B). Chromosomes 1 to X are represented on the x axis, while copy number is s
isoforms are labeled.
(E) Multicolor FISH staining of neochromosomes from the 778 and 449 cell lines
regions captured from the labeled native chromosomes, corresponding to the S
See also Figure S1.
Can(FISH) studies of all cell lines (Figure S1 available online)
indicated two to four linear neochromosomes per cell, all signif-
icantly larger than chromosome 1. The circular forms of neochro-
mosomes commonly reported in primary tumor cultures were
not seen (Pedeutour et al., 1994; Sirvent et al., 2000).
Size-based fluorescence-activated cell sorting separated and
purified the neochromosomes from other chromosomes for
sequencing studies (Figure 1C). The estimated enrichment of
the flow-isolated neochromosomes typically varied from 6-fold
for the 778 neochromosomes to 12-fold for the 449, and to
65-fold for the GOT3 neochromosomes (see Supplemental
Experimental Procedures for additional details), allowing
detailed analysis of these structures isolated from the remaining
genome. LPS141 was an exception, with 2-fold enrichment. The
778 and 449 neochromosomes were analyzed using Affymetrix
250k SNP arrays (Figure 1D). Comparison of whole-genome
copy number (778 in Figure 1D) to the isolated neochromosomes
(778A, 778B, 449A, and 449B) indicated that almost all highly
amplified regions are located on the neochromosomes. Striking
conservation was observed of regions of high-level gain between
neochromosomes from the 778 and 449 cell lines, despite their
independent derivation and ex vivo culture, attesting to the pri-
mary role of the amplified core of the neochromosome in tumor
development.
In contrast to amplified regions, major differences were
notable between neochromosome isoforms in low-copy regions,
including chromosome 7p (778A and 778B), chromosome 22
(778B), chromosome 5 (449A), chromosome 17 (449A), and
chromosome 4 (449B) (Figure 1D). Multicolor FISH studies
revealed that these regions are located at the telomeres in all
cell lines (Figure 1E and Figure S1). Telomeres are an obligate
feature of mammalian linear chromosomes. The variation be-
tween the 449 and 778 neochromosome isoforms suggests
that telomeres are acquired as secondary and independent
events arising after the establishment of the highly amplified
core, perhaps by telomere capture (Meltzer et al., 1993). Individ-
ual metaphases showed marked variation within and between
cell lines in neochromosome number and telomere patterns,
consistent with chromosomal instability (Figure S1). Karyotypic
analyses of the 778 cell line revealed at least two copies of the
giant chromosomes per metaphase. Both the T1000 line and
the GOT3 line had 45–47 chromosomes per metaphase and
showed a large, variable neochromosome consisting mainly of
material from chromosomes 1, 12, and X. In the LPS141 cell
line, at least two populations of neochromosomes were seen,
with the telomeres involving chromosomes 8 and 9, and perhaps
chromosomes 2 and 3.
High-Resolution Architecture of WD/DDLPS
Neochromosomes
DNA from flow-isolated neochromosomes (shown for the 778
cell line in Figure 1C) was amplified and sequenced, along withas well as four flow-sorted neochromosome isoforms (449A, 449B, 778A, and
hown on the y axis. The large low-copy regions distinguishing neochromosome
, demonstrating homogenously staining core regions and distinctive telomeric
NP data in (D).
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Figure 2. Neochromosome Architecture
(A) Schematic of the structure of the 778, 449, GOT3, T1000, and LPS141 neochromosomes. Chr, chromosome.
(B) CIRCOS diagrams showing copy number profiles and intrachromosomal (red) and interchromosomal (purple) fusions for the 778, 449, GOT3, T1000, and
LPS141 cell line neochromosomes, along with two primary tumors (ST059 and ST079).
See also Figure S2 and Tables S1 and S2.
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ST059 and ST079. Isolated neochromosome isoforms from
each cell line were pooled. In summary, between 7 (449) and
49 Gb (T1000) of DNA sequence was generated for each cell
line or primary tumor, with 32–382Mb at greater than 203 (Table
S1). Coverage of single-copy regions varied from 53 (449) to
273 (GOT3), with much greater coverage of amplified regions.
Our initial aim was to define precisely the size and structure of
the neochromosomes (Figure 2A). Although lacking recurrent
single nucleotide or insertion and deletion (or INDEL) varia-
tion of significance (Supplemental Experimental Procedures),
extreme structural rearrangement and copy number variation
was apparent (Figure 2B). Copy number was estimated by
counting aligned reads in 5 kb windows, correcting for guanine
and cytosine (GC) content and background and calibrating using
regions of known single copy (for example, chromosome 22
for 778B; Figure S2A). Thresholding copy number (Figure S2B)
and integrating fusion information identified neochromosomal
material (see Supplemental Experimental Procedures for de-656 Cancer Cell 26, 653–667, November 10, 2014 ª2014 Elsevier Inctails). The reference donor size for the five cell line neochromo-
somes were only 14 Mb (LPS141), 21 Mb (449), 23 Mb (778),
23 Mb (T1000), and 53 Mb (GOT3), derived unequally from
different chromosomes. The small size of the donor genomes
was amplified to between 150 Mb (LPS141) and 412 Mb
(GOT3; Figure 2A). Consistent with stability of the core, there
was 91% overlap between the 449 and 778 neochromosomes.
Including telomeric regions, the total size of the isolated
neochromomes varied from 279 Mb (LPS141) to at least 640
Mb (T1000). The GOT3, 449/778, T1000, LPS141, ST059,
and ST079 neochromosomes share in common 1.4 Mb
of donor sequence from chromosome 12, including the following
genes: MDM2, NUP107, HMGA2, CDK4, CPM, RAB3IP,
FRS2, MARCH9, AC025263.3, CCT2, TSPAN31, CYP27B1,
CNOT2, SLC35E3, AGAP2-AS1, AGAP2, AC124890.1, PTPRR,
KCNMB4, METTL1, LRRC10, MYRFL, PTPRB, and BEST3.
Synoptically, neochromosomes comprise hundreds of
highly amplified and rearranged fragments of DNA from every
chromosome (Figure 2B). High-level copy number changes are.
Cancer Cell
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ber states (Figures S2A and S2C). For example, in 778, quantized
copy number clusters equivalent to 1, 2, 4, 8, 16, and 32 copies
were observed across different chromosomes of origin, with
single-copy states for chromosome 22 and a mixture of single
and double- or triple-copy states for chromosome 7. The modal
copy number state on chromosome 12 was 16 copies, with a
maximum of 64 copies. Spatially, clusters of anomalously
aligned paired end reads were identified (see Supplemental
Experimental Procedures), yielding between 256 (449) and 586
(778) fusions, involving 6–18 different chromosomal partners
(Table S2). The 449 and 778 neochromosomes shared 70% of
fusions, with the gap likely attributable to differential read depth
(data not shown). Between 23% and 86% of fusions were
intrachromosomal. Forty-four of 50 (88%) randomly selected
representative fusions from the 778 neochromosome data
were validated by conventional PCR and sequencing. A detailed
analysis of the 778 neochromosome breakpoints showed fea-
tures of blunt end joining, or imperfect homology (<20 base pairs
[bp] of homology) (data not shown). Notably, many nonneochro-
mosomal translocations are also observed in our cell lines
(Figure S1).
Despite the complexity, clear patterns were discernible. Neo-
chromosomes comprise hundreds of spatially distinct, contig-
uous genomic regions (CGRs), illustrated by the CGR containing
the oncogene CDK4 (58,048–58,167 kb on 778 chromosome 12;
Figures 3A and 3B; Table S3). CGRs are islands in the reference
genome, flanked by regions effectively absent in the flow-iso-
lated neochromosome sequence data. The absence of signal
outside CGRs is not an artifact of read depth, since known sin-
gle-copy regions (e.g., chromosome 22) are readily detected at
53–273. CGRs range from 88 bp to 1.15 Mb (median, 26 kb),
and are highly rearranged and amplified. These rearrangements
generate two types of breakpoints (Figure 3B). The first defines
the edges of CGRs (e), with contiguous reads mapping on only
one side of the breakpoint. The second type lies internal to
CGRs (i) and is characterized by reads flanking both sides of
the breakpoint. These breakpoints give rise to three types of
fusion (Figure 3C). Fusions between the boundaries of two
CGRs are termed ‘‘edge-to-edge’’ (e2e) fusions. e2e fusions
linking CGRs are probably early events, arising at, or soon after,
incorporation of new material into the neochromosome. A sec-
ond fusion type links a break internal to a CGR to the edge of
another CGR (termed ‘‘edge-to-internal,’’ or e2i), and the third
type (‘‘internal-to-internal,’’ or i2i) links two CGRs internally.
The extraordinarily complex topology of the neochromosome
is shown by a graph of CGRs in the 778 neochromosome, with
nodes whose radius is proportional to maximal copy number,
and fusion types as edges (Figure S3A). A total of 177 e2e, 203
e2i, and 166 i2i fusions were identified within the 778 neochro-
mosome core. The highest copy CGRs are typically linked within
a tight network of i2i and e2i fusions, suggesting that these
fusions are related to amplification.
Different types of fusions have distinct properties. Analysis of
e2e fusions indicates that the neochromosome probably formed
from chromosome 12, with or without other contributory chro-
mosomes. For example, in the 778 neochromosome, although
chromosome 12 contributes less than 30% of the amplified
core of the neochromosome, 75% of chromosome 12 e2eCanfusions are intrachromosomal (Figure S3B). For comparison,
23% of chromosome 1 e2e fusions and 7% of chromosome 15
e2e fusions are intrachromosomal, despite representing 19%
and 12% of the neochromosome content, respectively. More-
over, 19 of the top 25 (76%) most highly amplified e2e fusions
involve at least one partner on chromosome 12, and both part-
ners come from chromosome 12 in 15 cases (60%). By contrast,
778 chromosome 12 e2i and i2i fusions involve diverse partners,
including itself (26%), chromosome 1 (12%), and chromosome
15 (9%). Assuming that e2e fusions primarily represent early
events, identifying ‘‘walkable’’ chains of e2e fusions may allow
insight into the early structure of neochromosomes. Continuous
walkable chains of CGRs entirely located on chromosome 12
were identified in several samples, with the longest chain of chro-
mosome 12 CGRs connecting 22 of 50 CGRs in the 778 neo-
chromosome (Figure 3D). In T1000, a mixture of CGRs from
chromosomes 12 and 10 form a similar set of walkable chains,
similar to another chain involving two distinct chromosomes
(chromosomes 13 and 16) in the 778 neochromosome (Fig-
ure S3C), and suggesting the synchronous engagement of two
distinct chromosomes. The average read depth for chromosome
12 e2e fusions is 165 ± 12, compared to 76 ± 10 for chromosome
1, the next most abundant chromosome. The earliest CGRs
incorporated into the neochromosome likely are the most
highly amplified, consistent with the early involvement of chro-
mosome 12.
e2e fusions are characterized by equal copy numbers on each
side of the fusions (average copy number ratio, 1.02 ± 0.03;
range = 0.6–1.6 in 778; Figures S3D and S3E), a likely conse-
quence of two CGRs introduced into the neochromosome simul-
taneously without amplification. By contrast, e2i fusions typically
comprise asymmetric copy number states (for example, in 778,
the ratio of ‘‘e’’ side to ‘‘i’’ side averages 0.32 ± 0.02), although
the range (0.02–1.2) includes copy-number-neutral fusions. i2i
fusions are characterized by a broad range of copy number ra-
tios (1–16). In summary, e2i and i2i events appear dominated
by progressive amplification and deletion events but also include
some early copy-number-neutral events. The distribution of
fusion types, their copy number states, and the presence of
walkable chains of e2e fusions likely reflects the order of events
during the life history of the neochromosome. The data suggest
an order of events in which chromosome 12 fusions demon-
strating copy number neutrality across the breakpoints (typically
but not exclusively e2e) most likely arise during initial assembly
or soon thereafter, while fusions involving marked differences
in copy number states on either side of the breakpoint
(again typically but not exclusively e2i and i2i) are generated
during subsequent amplification and deletion events on the
neochromosome.
Modeling the Evolution ofWD/DDLPSNeochromosomes
We sought to understand in greater detail the order of events
leading to neochromosome formation, starting with the initial for-
mation of an episomal, self-replicating structure. Double-minute
episomal structures have been observed in the context of
chromothripsis (Sanborn et al., 2013; Stephens et al., 2011).
Chromothripsis is a temporally and spatially limited phenomenon
characterized by chromosomal shattering and rearrangement,
without significant copy number change (Korbel and Campbell,cer Cell 26, 653–667, November 10, 2014 ª2014 Elsevier Inc. 657
Figure 3. Classification of Breakpoints and Fusions in CGRs on the Neochromosome
(A) Copy number profile from 778 showing adjacent CGRs containing the oncogene CDK4. Chr, chromosome.
(B) Higher resolution view of CGR at chromosomes 12:58.070-58; 165 Mb showing total read depth (top) and anomalously aligned reads (bottom). Edge
breakpoints (e) define the boundaries of the CGR, while internal breakpoints (i) correspond to rearrangements linking CGR internally to noncontiguous regions of
the genome. Note that the flanking regions on either side of the CGR contain only a low level of reads consistent with the absence of representation on the
neochromosome.
(C) The three classes of fusion: e2e, e2i, and i2i.
(D) The longest chains of e2e fusions between CGRs (blue rectangles) involving chromosome 12 on the 778 and ST059 neochromosomes and involving both
chromosomes 12 and 10 on the T1000 neochromosome. These represent the inferred structure of the original chromothriptic rearrangements.
See also Figure S3 and Table S3.
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walkable chromosome 12 e2e chains noted earlier typically do
not show marked copy number differences on either side of
the fusions (Figure 3D; Figures S3D and S3E). Other classical
features of chromothripsis affecting chromosome 12 seen in all
samples include clustering of breakpoints, monoallelic amplifi-
cation, and broadly equal numbers of deletion-type, tandem
duplication-type, and head-to-head and tail-to-tail intrachromo-
somal fusions (Korbel and Campbell, 2013) (Figure 4A, right
panel; Figures S4A and S4B). Chromothripsis is also suggested
by, for example, oscillating copy number states in the low-copy
regions of chromosomes 7 and 22 in the 778 neochromosomes
(Figure 4B), the telomeric fragment of chromosome 1 in the
GOT3 neochromosome (Figures 2B and S2A), and multiple re-
gions in LPS141 (Figure S2A). Taken together, these features
suggest that chromothripsis occurs early in the life cycle of the
neochromosome andmay later account for subsequent episodic
integration of newmaterial (see Supplemental Experimental Pro-
cedures and Table S4 for further details).
By definition, chromothripsis cannot account for high-level
copy number variation. Breakage-fusion-bridge (BFB) has
been linked to gene amplification in WD/DDLPS (Gisselsson
et al., 2000; Lo et al., 2002a). The dominant model for BFB as-
sumes a linear form, in which telomeric association and fusion
of homologous chromosomes form a dicentric chromosome
that breaks during each mitosis, leading to asymmetric segrega-
tion (Gisselsson et al., 2000). However, two features led us to
postulate a circular form of BFB (Figure 4C). First, the circular
neochromosomes frequently seen in primary WD/DDLPS
karyotypes are subsequently replaced by linear forms in cell
lines, where we observe stabilization of the core content of
the neochromosome (discussed earlier). More important, the
inverted duplications that are characteristic of linear BFB are
not observed in any neochromosome, and the proportions of
different fusion types (deletion type, tandem duplication type,
and inversion type with head-to-head or tail-to-tail orientation;
Korbel and Campbell, 2013), were uniform (Figures S4A
and S4B).
Modeling circular BFB without chromothripsis over several
thousand cell cycles, beginning with chromosome 12 (see Sup-
plemental Experimental Procedures for details), qualitatively
recapitulated the focal and discretized amplification, as well as
many features of e2e, e2i, and i2i fusions (Figures S4C and
S4D). However, BFB alone does not generate the inversions
observed empirically (Figure 4A, right panel; Figures S4A–S2C
and S4E). Moreover, even after several thousand cycles, the
number of chromosome 12 CGRs consistently reached an
asymptote <30, less than that empirically observed in all isolated
neochromosomes (50–90 CGRs; Figure 4D, left panel). Finally,
BFB alone fails to generate empirically observed CGR sizes (Fig-
ure S4F) or sustained walkable e2e chains of chromosome 12
CGRs (Figure S4G).
By contrast, incorporating chromothripsis (modeled by
randomly fragmenting chromosome 12q using the fragment
length distribution empirically observed in the chromothriptically
rearranged region of chromosome 7 in the 778 neochromosome)
into our model consistently recapitulated important observed
phenomena, including the number of chromosome 12 CGRs in
all lines (Figure 4D, right panel); equal proportions of fusion orien-Cantations (Figure 4A, left panel; Figure S4H); copy number ratios for
e2e, e2i, and i2i fusion types (Figure S4I); sustained walkable
chains of chromosome 12 CGRs linked by e2e fusions (Fig-
ure S4J); total number of e2e fusions (Figure S4K); and the me-
dian CGR size (Figure S4L; Movie S1). Together with empiric
evidence for chromothriptic events at other sites in the genome,
these data are consistent with a model in which chromothriptic
rearrangement of chromosome 12 is involved early in the forma-
tion of the ring chromosome, perhaps as the initiating event.
Notably, these models depend on the application of heuristic
locus-specific selective values, without which simulations invari-
ably resulted in complete loss of the neochromosome, suggest-
ing that any regions recurrently amplified in primary tumors
depend on a selective advantage of some kind to the evolving
cancer clone. A complete summary of the assumptions used in
developing this model is provided in the Supplemental Experi-
mental Procedures.
Centromeric Corrosion by BFB
Large-scale loss of material, a feature of both BFB and
chromothripsis, also has implications for key structural domain
of chromosomes. Normal human centromeres comprise
highly repetitive a-satellite DNA. WD/DDLPS neochromosomes
commonly possess neocentromeres arising on nonrepetitive re-
gions (Marshall et al., 2008a), observed as centromeric constric-
tions in the absence of alphoid DNA. For example, the 778 line
neochromosomes only possesses nonalphoid neocentromeres
(Figure S5). To fully characterize the neocentromere on the 778
neochromosomes, centromere protein A (CENP-A) chromatin
immunoprecipitation and sequencing (ChIP-seq) was performed
in the 778 cell line. Compared to either the input or a nonspecific
control, only two regions on the neochromosome were signifi-
cantly enriched in the CENP-A pulldown, constituting a 77.5 kb
region in chromosome 1q25.3 and an 8.5 kb region in chromo-
some 6q21 (Figure 5A). Both regions are linked by an e2i fusion,
suggesting that the neocentromere assembled on a single,
contiguous domain from both chromosomes 1 and 6. Confirming
the ChIP-seq data, a bacterial artificial chromosome (BAC) from
chromosome 1 that spans the 77.5 kb binding domain colocal-
ized with CENP-A at the centromere of the neochromosomes
via immuno-FISH (Figure 5B). Since the regions from chromo-
somes 1 and 6 that comprise the 778 neocentromere were not
involved in the initial formation of the ring (discussed earlier),
neocentromere formation appears to be a late acquisition during
the evolution of the neochromosome.
We next looked for examples of neochromosomes that con-
tained alphoid centromeres. The GOT3 cell line (Figure 5C)
possesses a faint active alphoid centromere located within the
oncogenic amplified material. This alphoid centromere, derived
from chromosome 1, had lost 64% of the a-satellite-specific re-
peats, as determined by quantitative FISH (p < 0.001, n = 3; Fig-
ure 5Da). Similarly, an inactive, attenuated centromere derived
from chromosome 5 was observed on the arms of two of the
four neochromosomes present in the 449 cell line. This centro-
mere had lost 78% of its satellite repeats, as determined via
quantitative FISH (p < 0.001, n = 7; Figure 5Db), retaining sin-
gle-copy adjacent pericentric DNA from chromosome 5p on
both neochromosomes (Figures 5Ea and 5Eb). Additional sin-
gle-copy nonalphoid material from the 5p pericentric regioncer Cell 26, 653–667, November 10, 2014 ª2014 Elsevier Inc. 659
(legend on next page)
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ure 5Ec). Combining the FISH probe and sequencing data, the
multiple breakpoints mapped on each neochromosome isoform
(Figure 5F) provides evidence of progressive states of attrition
and corrosion of a-satellite and surrounding pericentric DNA.
Assuming that the centromere is eventually lost through BFB, it
may be replaced by neocentromere formation utilizing nonal-
phoid regions as seen in the 778 cell line.
Transcriptional Consequences of Genomic
Rearrangement on the Neochromosome
In integrating data from the 449/778, GOT3, and T1000 cell
lines, we found that 107 coding units were highly amplified
(>10 copies) in all cell lines (Table S5). Fifty-two represented
curated protein coding transcripts, as well as 7 microRNAs,
11 splicesomal or small nucleolar RNAs, 14 pseudogenes, 8
large, intergenic noncoding RNAs, and several less well-curated
transcripts. Transcriptome sequencing of the 449/778, GOT3,
and T1000 cell lines was performed and correlated with copy
number (Table S5). Across the 449/778, GOT3, and T1000 cell
lines, the average reads per kilobase million (RPKM) for genes
with a median copy number >10 was 38, compared to an
average RPKM of 10 for genes with a median copy number
between 2 and 10, and an average RPKM of 3 for genes with
a median copy number of 2 or less. Among the most abundant
and curated protein coding transcripts are MDM2 (a median of
281 RPKM), OS9 (243 RPKM), CDK4 (164 RPKM), YEATS4 (85
RPKM), and NUP107 (77 RPKM). However, some amplified
genes are transcriptionally silent. For example, FASLG (chromo-
some 1: 172,628,185–172,636,012), an important proapoptotic
regulator of the extrinsic death pathway, is frequently amplified
(778 cell line, 36 copies; 449 cell line, 22 copies; and GOT3 cell
line, 11 copies) but expressed at fewer than 1 RPKM in any line.
Detailed analysis of the 778 cell line revealed that promoter
methylation within amplified regions correlated with lower
expression (mean ± SE: 0.46 ± 0.05 for genes with low RPKM
versus 0.18 ± 0.05 for genes with high RPKM, p < 0.001). The
average promoter CpG methylation of FASLG in the 778 cell
line was 0.8, compared to 0.12 for CDK4 and 0.11 for MDM2.
These data suggest that epigenetic silencing is permissive for
amplification of loci containing genes whose overexpression
would otherwise not be tolerated. Interestingly, where a break-
point dissociates the native promoter from the coding unit of a
gene, promoter methylation correlated poorly with gene expres-
sion (r2 = 0.01, p = 0.61), compared to intact genes (r2 = 0.28,
p < 0.001), consistent with disruption of normal mechanisms
of regulatory control.Figure 4. Evidence Supporting Chromothriptic Origins of WD/DDLPS N
(A) A selected copy number and fusion orientation profile from the BFB + chrom
chromosome 12 (Chr12) from the 778 neochromosome (right).
(B) Copy number profiles and different class of intrachromosomal rearrangement
to-head and TT, tail-to-tail) of the telomeric caps of the 778 neochromosomes—
(C)Model of circular BFB: (left to right) the circular neochromosome replicates and
dicentric neochromosome is formed; at cell division, the centromeres are pulle
amounts of DNA containing duplicated and deleted regions, which we score for
(D) Evolution of the number of CGRs generated by the BFB-only (left) and the B
possible lineage. Only one cell is followed at each cycle, selected at random
chromosome 12 CGRs observed in 778 (green), GOT3 (red), LPS141 (blue), T100
See also Figure S4, Table S4, and Movie S1.
CanMassive rearrangement of the neochromosome may affect
transcript splicing or generate fusion transcripts. By integrating
predicted breakpoints and fusion transcripts identified using
RNA sequencing data (see Supplemental Experimental Proce-
dures for methods), we identified 0 (449) to 4 (778) putative fusion
genes (data not shown). No recurrent fusion genes were found.
Interestingly, in 778, the head-to-head or tail-to-tail orientation
of these putative fusion genes indicates that they are unlikely
to constitute oncogenic drivers; however, transcripts using
cryptic exons located in intronic or intergenic regions were
also identified. For example, a reciprocal translocation between
YEATS4 (chromosome 12) and TAF3 (chromosome 10) results in
a highly expressed exon in the antisense orientation located
within the second intron of TAF3 (Figure S6), upstream of a
tail-to-tail fusion with the sixth intron in YEATS4. YEATS4 was
recently identified as an amplified oncogene in WD/DDLPS (Bar-
retina et al., 2010). The resulting fusion was verified by direct
sequencing of the predicted transcript, replacing a coiled-coil
domain encoded in exon 7 of YEATS4. Notably, alternate tran-
scripts were identified that introduced a premature stop codon
after exon 6 of YEATS4, also deleting the coiled-coil domain.
Since the C terminus coiled-coil domain of YEATS4 elicits a
p53 response, this may provide a selective growth advantage
for WD/DDLPS (Park and Roeder, 2006).
Functional Analysis
The model predicts that recurrently amplified regions must
confer a selective advantage on the evolving cancer cell; in
some cases, by oncogene overexpression. To identify putative
oncogenes, we undertook a census of amplified and over-
expressed genes in 131 primary connective tissue tumors,
including 15 WD/DDLPS tumors (D.W.G. and D.M.T., unpub-
lished data). The most frequently amplified genes in WD/
DDLPS (>70%) are located at 12q14.1-15 (Table S6). Of the
49 recurrently amplified genes (>30% of WD/DDLPS) located
on chromosome 12, there were 16 genes whose expression
levels were higher in WD/DDLPS compared to other sarcoma
subtypes (>1.5-fold; p < 0.001). We further refined the list of
candidate driver genes by defining the subset of genes that
are also amplified (copy number > 20) and overexpressed
(RPKM > 100) in three WD/DDLPS cell lines (449, GOT3, and
T1000; Table S5; (Figure 6A; Table S7). To determine whether
these candidates are required for viability and growth, we per-
formed small interfering RNA (siRNA) knockdown on the top
ranked four genes (OS9, CDK4, MDM2, and NUP107) in two
cell lines with copy number profiles representative of primary
tumors (449 and 778). The effect on cell growth was measuredeochromosomes
othripsis model after 1,000 cycles (left) compared to the observed profile for
(D, deletion type; TD, tandem duplication type; and inversion types: HH, head-
chromosomes 7 (Chr7, left) and 22 (Chr22, right).
enters a BFB cycle if an odd number of crossover events occurs; in this event, a
d apart and two double-strand breaks occur; daughter cells inherit unequal
fitness using a heuristic model.
FB + chromothripsis (right) models. Each black line follows the evolution of a
with probability biased toward the fittest. Color lines indicate the number of
0 (purple), ST059 (yellow), and ST079 (cyan).
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Figure 5. Characterization of WD/DDLPS Centromeres and Neocentromeres
(A) CENP-AChIP-seq on the 778 cell line revealed a single neocentromere forming on linked regions from chromosomes 1 (Chr1) and 6 (Chr6). Log2 ratio of CENP-
A pulldown over input is shown in blue. CENP-A binding peaks (false discovery rate [FDR] <0.001) are demarcated in red. Anomalous reads indicating an e2i
fusion between chromosomes 1 and 6 is shown. Black line with arrowhead indicates the fusion and orientation.
(B) Combined immuno-FISH using an anti-CENP-A antibody and the RP11 BAC 1053i8 as a FISH probe demonstrates that the region from chromosome 1q25.3
identified by ChIP-seq colocalizes with CENP-A at the 778 neocentromere.
(C) FISH studies of GOT3 neochromosome reveal a faint alphoid centromere (pan-a) present within amplified material (whole chromosome paint from 778
neochromosomes; NC wcp). Cohybridization with wcp for chromosomes 12 (green) and 1 (red) shows that the centromere was originally derived from chro-
mosome 1; centromeric hybridization of the chromosome 1/5/19-specific satellite probe pZ5.1.
(D) Quantitative FISH of a-satellite sequences within the amplified core of the GOT3 (a) and 449 (b) neochromosomes demonstrates loss of satellite repeats
compared to native centromeres. Error bars represent SEM.
(E) Three 449 neochromosomes (a-c) show an inactive centromere derived from Chr5 (pan-alphoid probe), the amplified core (NC wcp), and adjacent pericentric
material from Chr5p. Labels refer to the FISH probe (green), counterstained with DAPI (magenta). Where two FISH probes colored green/red are used, DAPI
counterstain is in blue. BAC numbers refer to the RP11 library.
(F) Pericentric breakpoints identified by BAC hybridization and sequencing for each 449 neochromosome.
See also Figure S5.
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The Life Cycle of Cancer Neochromosomesby MTS assay after 3 to 5 days (Supplemental Experimental
Procedures; Table S7). Consistent with the principle that genes
recurrently amplified in WD/DDLPS confer a selective advan-
tage, the median decrease in cell viability following knockdown
was 31.78% (range = 0.23%–84.8%), compared to control
siRNA.662 Cancer Cell 26, 653–667, November 10, 2014 ª2014 Elsevier IncThis study confirms the prevalence of two known oncogenes
(MDM2 and CDK4) (Italiano et al., 2008; Pedeutour et al., 2012;
Pilotti et al., 1998), and identified a previously noted amplified
gene (OS9; Su et al., 1996). NUP107, a nucleoporin overex-
pressed in cancer (Agudo et al., 2004; Banerjee et al., 2010),
was also identified. Located 65,499 bp 50 of MDM2, NUP107 is.
Figure 6. Screen for Candidate Driver Genes in WD/DDLPS
(A) Venn diagram showing chromosome 12 genes that are recurrently amplified and overexpressed in WD/DDLPS primary tumors and cell lines. Genes selected
were frequently amplified in primary WD/DDLPS (>30%), and are expressed more than 1.5-fold higher in WD/DDLPS (n = 15) compared to a panel of other
sarcoma subtypes (n = 116; corrected p value < 0.001). Candidates were further filtered to identify chromosome 12 genes that are highly amplified (median copy
number >20) and expressed (median RPKM >100) in three WD/DDLPS cell lines (449, GOT3, and T1000).
(B) Top: relative expression ofCDK4,MDM2,NUP107, andOS9 in 15WD/DDLPS samples compared to a pool of 116 other sarcomas. Bottom: the same analysis
using an independent set of 105 sarcomas, including 18WD/DDLPS samples (National Center for Biotechnology Information Data Set Browser record GDS2736;
Nakayama et al., 2007). Box-and-whisker plots show log2 gene expression distribution (**** p < 0.0001, two-tailed t test).
(C) Effect of NUP107 depletion using siRNA in NUP107 amplified cell lines (449, 778, T1000, and GOT3) and unamplified cells (SW872 and NHB). Non-silencing
siRNAs (siNS) or pooled siRNAs were used as indicated, and viability was assessed by MTS assay 3 to 5 days after transfection (mean ± SE of three independent
experiments; two-tailed t test: *p < 0.05, ***p < 0.001).
(D) Cell-cycle distributions of cells treated with siRNAs targeting NUP107 and assessed as described in Supplemental Experimental Procedures. Data represent
the mean of two independent experiments.
See also Figure S6 and Tables S5, S6, and S7.
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The Life Cycle of Cancer Neochromosomesfrequently amplified (9/17) and is overexpressed in WD/DDLPS
tumors compared to other sarcomas in two independent expres-
sion data sets (Figure 6B, top and bottom panels). Validation
siRNA experiments confirmed the effect of NUP107 depletion
in WD/DDLPS cells (Figure 6C). Cells with amplified NUP107
(449, 778, T1000, and GOT3) were more sensitive to NUP107
knockdown (33.7% to 71.8% decrease in cell viability) than cells
lacking NUP107 amplification (normal human-bone-derived
[NHB] and SW872; 1.98% to 16.7%). NUP107 depletion induced
cell cycle arrest in 449 cells, whereas SW872 cells were relativelyCanunaffected (Figure 6D). Taken together, these data suggest that
NUP107 amplification and overexpression provide a growth
advantage in WD/DDLPS tumors.
DISCUSSION
In this study, we used deep molecular analyses to characterize
the architecture, evolution, and functional properties of cancer
neochromosomes. An exhaustive structural and cytogenetic
analysis from several WD/DDLPS cell lines enabled us to modelcer Cell 26, 653–667, November 10, 2014 ª2014 Elsevier Inc. 663
Figure 7. Model of Neochromosome
Evolution
The life history consists of three phases, which
we label Initiation, Amplification, and Linearization.
During, or soon after initiation, chromothripsis of
chromosome 12 contributes to the assembly of a
ring chromosome consisting of rearranged chro-
mosome 12 DNA, including oncogenic sequences
and possibly containing a native alphoid centro-
mere (red circle). The amplification phase is char-
acterized by multiple rounds of circular BFB
that shuffles and amplifies loci under selection,
as well as loss of other regions. DNA from
other chromosomes may be captured, possibly
by a process involving chromothripsis (yellow
segment). Centromeric crises (dashed circle)
created by progressive corrosion are resolved by
neocentromere formation (bullseye) or centromere
capture (yellow circle). The amplification phase
appears to be extinct in all lines studied. The
final phase is defined by linearization, chromo-
thriptic telomere capture, and continued genomic
instability.
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The Life Cycle of Cancer Neochromosomesthe process of neochromosome formation, from its earliest ori-
gins to the final forms visible in the cell lines and tumors studied
here (summarized in Figure 7). Although the exact ordering of
initial events remains a matter of speculation, chromothriptic
fragmentation of chromosome 12q appears an early and impor-
tant event in the formation of a circular structure (Figure 7, left
panel). This interpretation is also consistent with the double mi-
nutes observed in chromothriptic tumors (Sanborn et al., 2013;
Stephens et al., 2011) but does not formally exclude the possi-
bility that chromothripsis occurs soon after the formation of the
initial episomal structure; for example, by fusion of double-
strand breaks on each chromosome arm or telomere fusion.
A core group of genes located on chromosome 12 is almost
invariably amplified in WD/DDLPS, including MDM2 and CDK4.
Mdm2 was originally cloned from circular, episomal double-min-
ute structures in murine 3T3 cells (Cahilly-Snyder et al., 1987).
Recently, acentric double minutes in glioblastoma were studied
by whole-genome sequencing (Sanborn et al., 2013). These
studies, performed at 303 coverage on whole-tumor DNA,
demonstratedasimilarpatternofstructural contiguitywithinstruc-
tures typically around amegabase in size and that, inmany cases,
also containedMDM2. Almost-perfect homozygosity of amplified
material in our isolated neochromosomes suggests that DNA is
incorporated in a single event fromonedonor chromatid. The typi-
cally chromothriptic patterns at the junction of captured telomeric
regions suggests that this process is also associated with subse-
quent integration of new DNA into established neochromosomes.
Such new integrations may involve the fusion of isoforms of neo-
chromosomes themselves, where (as frequently observed) more
than one neochromosome exists per cell.
After assembly of the initial single-copy, circular, extrachro-
mosomal structure, hundreds of BFB cycles subsequently
mediate amplification of loci under selection, along with deletion664 Cancer Cell 26, 653–667, November 10, 2014 ª2014 Elsevier Inc.of other regions (Figure 7, center panel).
BFB was first identified in maize
(McClintock, 1941) and has been pro-posed as a mechanism for gene amplification in cancer (Bignell
et al., 2007; Gisselsson et al., 2000; Lo et al., 2002a). Since BFB
of linear dicentric chromosomes results in inverted duplications
(Bignell et al., 2007) not observed in our data, and since the pro-
portions of different classes of fusions (deletion type, tandem
duplication type, head to head, and tail to tail) remain uniform
despite amplification, we propose an alternative form of BFB,
in which a doubled, fused dicentric ring forms following an odd
number of sister chromatid exchanges. Ring forms are common
in primary WD/DDLPS (Nord et al., 2013) and were originally
observed in tumor metaphases of the 449 cell line (Sirvent
et al., 2000). Their replacement by the observable exclusively
linear forms seen in the cell lines may explain the ex vivo stabili-
zation of the neochromosome core in vitro. All cell lines now also
demonstrate a near-tetraploid state, perhaps explaining the
presence of multiple neochromosomes per cell, despite early
metaphases of the original primary tumors being frequently
diploid. The progressive replacement of ring by linear episomal
structures has been observed previously and may represent a
general phenomenon (Levan et al., 1978). Indeed, episodic line-
arization during tumor development may account for incorpora-
tion of additional regions of DNA into the neochromosome by
telomere capture, originally described in melanoma (Meltzer
et al., 1993). Progressive genomic instability, a feature of tumor
chaotropy, may favor the linear form of the neochromosome
and contribute to dedifferentiation in vivo. Such a transition de-
pends on the lack of selection for BFB-mediated amplification
of oncogenes, a state that inevitably occurs when ongoing
amplification of genes such as MDM2 and CDK4 provides no
additional selective benefit.
BFB is also associated with loss of DNA from the neochromo-
some, potentially accounting for the prevalence of neocentro-
meres in WD/DDLPS neochromosomes. The neocentromere
Cancer Cell
The Life Cycle of Cancer Neochromosomeson the 778 neochromosomes spanned conjoined regions from
chromosomes 1 and 6. Given that these regions are nonaborigi-
nal, this neocentromere is a descendant of the original centro-
mere used by the 778 neochromosomes. Not all WD/DDLPS
neochromosomes contain neocentromeres. Two WD/DDLPS
cell lines (GOT3 and 449) showed clear evidence of either active
or inactive alphoid centromeres on neochromosomes, with
attenuated levels of a-satellite DNA likely due to progressive
BFB-mediated centromere corrosion. Reduction of centromeric
a-satellite DNA has previously been noted in human chromo-
somes containing repositioned human neocentromeres (Amor
et al., 2004; Tyler-Smith et al., 1999), supporting the idea that
centromere deactivation is a driver for subsequent neocentro-
mere formation (Marshall et al., 2008a). In WD/DDLPS, the orig-
inal alphoid centromere in the newly formed neochromosome
may be replaced either by neocentromere formation or by the
capture of another native alphoid centromere.
Active selection is required for recurrent representation of
donor regions within the WD/DDLPS neochromosome, including
those acquired later in the life cycle.Onekindof selection involves
the amplification and overexpression of oncogenes. Many genes
that are amplified in more than half of all primary WD/DDLPS are
functionally important, including MDM2, CDK4, YEATS4, OS9,
andHMGA2, all genes located in a 12 Mb region of chromosome
12q (58–70Mb) pivotal to the initial formation of the episomal ring
structure (Nord et al., 2013).NUP107, also identified recently in an
integrative array-based study of soft tissue tumors (Nord et al.,
2013), may have oncogenic properties. Located on chromosome
12q, NUP107 belongs to the nucleoporin family of holoenzyme
subunits constituting the nuclear pore complex. The yeast
homolog of NUP107, Nup84, anchors telomeric regions of chro-
mosomes and is required for efficient repair of subtelomeric
DNA double-strand breaks (Nagai et al., 2008; Palancade et al.,
2007; Therizols et al., 2006). NUP107 is overexpressed in breast
cancer, where expression correlates with poor prognosis (Agudo
et al., 2004), and appears to have antiapoptotic functions in astro-
cytoma (Banerjee et al., 2010). However, not all amplified genes
areoverexpressed.A layerof epigenetic transcriptional regulation
silences amplified genes whose expression may be deleterious,
such as the proapoptotic gene FASLG. Regions may also
be selected because of locus-specific noncoding functions,
exemplified by neocentromere formation on regions from chro-
mosomes 1 and 6. Both chromosomes 1 and 6 are amplified
recurrently in WD/DDLPS (Forus et al., 2001; Nilsson et al.,
2004; Nord et al., 2013; Tap et al., 2011).
Cancers often have signature mutagenic patterns, ranging
from single-nucleotide changes to gross genomic instability.
The present study adds to other recently described and unique
chromosome-scale mutations, including chromothripsis itself
(Stephens et al., 2011), kataegis (Nik-Zainal et al., 2012), the
low-level amplification of megabase-scale regions of chromo-
some 21 in subtypes of childhood leukemia (Li et al., 2014),
and double minutes (Sanborn et al., 2013). Confirming recent
data (Li et al., 2014), we provide further evidence for the combi-
nation of chromothripsis and BFB cycles in tumor evolution. Our
data indicate that the generation of neochromosomes in WD/
DDLPS requires hundreds of circular BFB cycles to generate
the recurrent high-level, focal amplification observed in these
massive structures. These corrosive forces are sculpted byCanintense selection. The region of chromosome 12 that nucleates
formation of the neochromosome contains two potent onco-
genes critical to cellular immortalization, targeting the p53
(MDM2) and retinoblastoma (CDK4) tumor suppressor pathways
(Nord et al., 2013). Taken together, these studies reveal the com-
plex architecture and life cycle of a cancer-specificmutation on a
chromosome scale.
EXPERIMENTAL PROCEDURES
Cell Lines and Tumor Samples
A total of 449 cells were established from a primary retroperitoneal WDLPS
from a 68-year-old woman in 1993, and the 778 cells were derived from the
same patient’s retroperitoneal relapse in 1994 (Sirvent et al., 2000). GOT3 cells
were established from the first local recurrence of a WDLPS located close to
the left kidney of a 76-year-old woman (Persson et al., 2008). T1000 cells
were generated from a mixed WD/DDLPS arising from the thigh in a 43-
year-old male (Pedeutour et al., 2012). The LPS141 cell line was generated
from a dedifferentiated liposarcoma in a patient with recurrent disease (Snyder
et al., 2009). SW872 cells were from the American Type Culture Collection
(HTB-92). Cells were maintained in RPMI 1640 or Dulbecco’s modified Eagle’s
medium/F-12 supplemented with 10% FBS and 200 mM GlutaMAX (Invitro-
gen). NHB cells were grown as described elsewhere (Kansara et al., 2009).
Fresh frozen samples (152) were collected from patients diagnosed with a
variety of bone and soft tissue tumors, including WD/DDLPS, myxoid liposar-
coma, Ewing’s sarcoma, synovial sarcoma, leiomyosarcoma, undifferentiated
pleomorphic sarcoma (also known as malignant fibrous histiocytoma), osteo-
sarcoma, malignant peripheral nerve sheath tumor, chondrosarcoma, lipoma,
schwannoma, and desmoid tumor. Samples were obtained with appropriate
informed consent under the auspices of the Peter MacCallum Cancer Centre
Institutional Human Research Ethics Committee (Research Protocol 03/49).
None of the cell lines or primary tumors were exposed to clastogenic therapy
(chemotherapy or ionizing radiation), with the exception that this information
was not available for the LPS141 cell line.
Chromosome Preparation, Staining, and Isolation
Adherent cells were grown to approximately 70% confluence and treated with
100 ng/ml KaryoMAX Colcemid Solution (GIBCO) for 16 hr to arrest cells in
metaphase. Chromosomes were extracted and stained, and neochromo-
somes were isolated by flow cytometry, as previously described (Marshall
et al., 2008b), on a flow cytometer (MoFlo, DAKO). Individual and pooled pop-
ulations of neochromosomes were isolated based on the flow karyotype.
Next-Generation Sequencing
Pooled isolated neochromosomes from the 778, 449, GOT3, T1000, and
LPS141 cell lines; whole-genome DNA from two patient samples, ST059
and ST079; and the ChIP-seq libraries were sequenced on the Illumina GAIIx
and HiSeq 2000 platforms (see Table S1 for details).
The complete materials and methods are provided in the Supplemental
Experimental Procedures.
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Sequence data are accessible from the European Nucleotide Archive (http://
www.ebi.ac.uk/ena/) under accession number ERP004006.
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